1998
DOI: 10.1136/pgmj.74.872.382-b
|View full text |Cite
|
Sign up to set email alerts
|

Sarcoidosis-lymphoma syndrome in a woman with acromegaly

Abstract: disposition following concomitant administration of ketoprofen, piroxicam and flurbiprofen in patients with rheumatoid arthritis. BrJ Clin Pharmacol 1994; 37:453-6. 4 Mason P. Fish oils. In: Mason P, ed. Handbook of dietary supplements, Oxford: Blackwell Science Ltd, 1995; pp 73-8. 5 Harvey SC, Withrow CD. Cardiovascular drugs. In: Gennaro AR, ed. Remington's Pharmaceutical sciences. Pennsylvania: Mack Publishing Company, 1990; pp 858-9. * Correct within an order of magnitude = Wrong. * It is clear... = It is … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2006
2006
2007
2007

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 4 publications
0
1
0
Order By: Relevance
“…It has been postulated that the increased mitotic activity of lymphocytes in sarcoidosis due to the immune inflammatory response in the involved tissues may increase the risk of mutation and subsequent malignant transformation of lymphocytes 93 . In addition to Hodgkin's disease, 84,90,94,95 other hematologic malignancies have occurred in patients with a previous diagnosis of sarcoidosis of more than 1 year in duration: non‐Hodgkin's lymphoma, 90,94,96–98 myeloma, 90,92 acute myelogenous leukemia, 99–101 hairy cell leukemia, 102 chronic myelogenous leukemia, 103 Epstein–Barr virus‐associated lymphoproliferative disease, 104 lymphoproliferative disorders, 93 myeloproliferative disorder, 93 chronic lymphocytic leukemia, 90 mycosis fungoides, 90 and T‐cell granular lymphocytic leukemia 94 …”
Section: Sarcoidosismentioning
confidence: 99%
“…It has been postulated that the increased mitotic activity of lymphocytes in sarcoidosis due to the immune inflammatory response in the involved tissues may increase the risk of mutation and subsequent malignant transformation of lymphocytes 93 . In addition to Hodgkin's disease, 84,90,94,95 other hematologic malignancies have occurred in patients with a previous diagnosis of sarcoidosis of more than 1 year in duration: non‐Hodgkin's lymphoma, 90,94,96–98 myeloma, 90,92 acute myelogenous leukemia, 99–101 hairy cell leukemia, 102 chronic myelogenous leukemia, 103 Epstein–Barr virus‐associated lymphoproliferative disease, 104 lymphoproliferative disorders, 93 myeloproliferative disorder, 93 chronic lymphocytic leukemia, 90 mycosis fungoides, 90 and T‐cell granular lymphocytic leukemia 94 …”
Section: Sarcoidosismentioning
confidence: 99%